Pictet Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$292M Buy
830,595
+156,855
+23% +$55.9M 0.31% 79
2025
Q4
$221M Buy
673,740
+32,553
+5% +$10.3M 0.21% 116
2025
Q3
$179M Sell
641,187
-248,094
-28% -$72M 0.17% 139
2025
Q2
$248M Sell
889,281
-20,726
-2% -$5.87M 0.25% 104
2025
Q1
$282M Buy
910,007
+291,017
+47% +$85.9M 0.31% 86
2024
Q4
$161M Sell
618,990
-271,270
-30% -$80.5M 0.17% 148
2024
Q3
$287M Sell
890,260
-53,505
-6% -$17.5M 0.32% 84
2024
Q2
$295M Sell
943,765
-443,619
-32% -$130M 0.34% 71
2024
Q1
$395M Sell
1,387,384
-580,100
-29% -$170M 0.43% 57
2023
Q4
$567M Sell
1,967,484
-33,593
-2% -$9.15M 0.63% 36
2023
Q3
$538M Buy
+2,001,077
New +$499M 0.66% 32

Other funds holding AMGN

Pictet Asset Management's AMGN Position: Q1 2026 in Review

Pictet Asset Management increased its Amgen (AMGN) stake by 23% in Q1 2026, buying an estimated $55.9M and bringing the position to 830,595 shares worth $292M. The position accounts for 0.31% of the portfolio, ranked #79.

Pictet Asset Management first reported a position in AMGN in Q3 2023 and has held it in 11 quarters since. The position peaked at $567M in Q4 2023. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Pictet Asset Management held 830,595 shares of Amgen worth $292M as of Q1 2026.
  • Pictet Asset Management bought 156,855 Amgen shares in Q1 2026, an estimated $55.9M.
  • Amgen made up 0.31% of Pictet Asset Management's portfolio in Q1 2026, its #79 holding.
  • Pictet Asset Management first reported a position in Amgen in Q3 2023 and has held it in 11 quarters since.
  • Pictet Asset Management's Amgen position peaked at $567M in Q4 2023.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.